Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
42.8M
-
Shares change
-
+5.59M
-
Total reported value, excl. options
-
$3.1B
-
Value change
-
+$399M
-
Number of buys
-
90
-
Number of sells
-
-21
-
Price
-
$72.52
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q4 2020
126 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q4 2020.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.8M shares
of 75.6M outstanding shares and own 56.59% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.41M shares), Bain Capital Life Sciences Investors, LLC (7.28M shares), PERCEPTIVE ADVISORS LLC (4.18M shares), FMR LLC (3.38M shares), BlackRock Inc. (2.25M shares), BOXER CAPITAL, LLC (2.08M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.44M shares), ArrowMark Colorado Holdings LLC (1.29M shares), VANGUARD GROUP INC (1.27M shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (1.16M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.